Literature DB >> 15378797

Clinical significance of preoperative regional intra-arterial infusion chemotherapy for advanced gastric cancer.

Cheng-Wu Zhang1, Shou-Chun Zou, Dun Shi, Da-Jian Zhao.   

Abstract

AIM: Preoperative intra-arterial infusion chemotherapy could increase the radical resection rate of advanced gastric cancer, but its effect on the long-term survival has not been assessed. This study was designed to evaluate the clinical significance of preoperative intra-arterial infusion chemotherapy for advanced gastric cancer.
METHODS: Clinicopathological data of 91 patients who underwent curative resection for advanced gastric cancer were collected. Among them, 37 patients undertaken preoperative intra-arterial infusion chemotherapy were used as the interventional chemotherapy group, and the remaining 54 patients as the control group. Eleven factors including clinicopathological variables, treatment procedures and molecular biological makers that might contribute to the long-term survival rate were analyzed using Cox multivariate regression analysis.
RESULTS: The 5-year survival rate was 52.5% and 39.8%, respectively, for the interventional group and the control group (P<0.05). Cox multivariate regression analysis revealed that the TNM stage (P<0.001), preoperative intra-arterial infusion chemotherapy (P = 0.029) and growth pattern (P = 0.042) were the independent factors for the long-term survival of patients with advanced gastric cancer.
CONCLUSION: Preoperative intra-arterial infusion chemotherapy plays an important role in improving the prognosis of advanced gastric cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15378797      PMCID: PMC4576275          DOI: 10.3748/wjg.v10.i20.3070

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

1.  Effect of preoperative regional artery chemotherapy on proliferation and apoptosis of gastric carcinoma cells.

Authors:  Hou-Quan Tao; Shou-Chun Zou
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 2.  A systematic overview of chemotherapy effects in gastric cancer.

Authors:  K G Janunger; L Hafström; P Nygren; B Glimelius
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

3.  [Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer].

Authors:  T Kosaka; N Ueshige; J Sugaya; Y Nakano; T Akiyama; F Tomita; H Saito; I Kita; S Takashima
Journal:  Gan To Kagaku Ryoho       Date:  1998-07

4.  Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.

Authors:  J Hermans; J J Bonenkamp; M C Boon; A M Bunt; S Ohyama; M Sasako; C J Van de Velde
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

5.  Comparison of prognostic significance of nodal staging between old (4th edition) and new (5th edition) UICC TNM classification for gastric carcinoma. International Union Against Cancer.

Authors:  C H Yoo; S H Noh; Y I Kim; J S Min
Journal:  World J Surg       Date:  1999-05       Impact factor: 3.352

Review 6.  Prognostic factors in gastric cancer.

Authors:  H Allgayer; M M Heiss; F W Schildberg
Journal:  Br J Surg       Date:  1997-12       Impact factor: 6.939

7.  [Pharmacokinetics of "subselective" arterial infusion chemotherapy].

Authors:  Y Tokairin; M Maruyama; H Baba; T Yoshida; N Kure; T Nagahama; M Ebuchi
Journal:  Gan To Kagaku Ryoho       Date:  2001-10

8.  [Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy].

Authors:  M Masuyama; H Taniguchi; K Takeuchi; K Miyata; H Koyama; H Tanaka; T Higashida; Y Koishi; T Mugitani; T Yamaguchi
Journal:  Gan To Kagaku Ryoho       Date:  1994-09

Review 9.  News of TNM and its use for classification of gastric cancer.

Authors:  P Hermanek; C Wittekind
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

10.  [Effect of preoperative intra-arterial chemotherapy on apoptosis and p53 expression of gastric cancer].

Authors:  Xin-chun Dong; Bin Li; Ying-ping Li
Journal:  Ai Zheng       Date:  2002-10
View more
  10 in total

1.  Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

Authors:  Wei Li; Jing Qin; Yi-Hong Sun; Tian-Shu Liu
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

2.  Percutaneous needle decompression in treatment of malignant small bowel obstruction.

Authors:  Ting-Hui Jiang; Xian-Jun Sun; Yue Chen; Hui-Qin Cheng; Shi-Ming Fang; Hao-Sheng Jiang; Yan Cao; Bing-Yan Liu; Shao-Qiu Wu; Ai-Wu Mao
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

3.  Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.

Authors:  Lei Ge; Hai-Jiang Wang; Dong Yin; Cheng Lei; Jin-Feng Zhu; Xiao-Hui Cai; Guo-Qing Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

4.  Targeted treatment of liver metastasis from gastric cancer using specific binding peptide.

Authors:  Jianfeng Gong; Gewen Tan; Nengquan Sheng; Weiqiang You; Zhigang Wang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

5.  Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy.

Authors:  Zhen-Feng Wu; Qin-Hong Cao; Xiao-Yu Wu; Che Chen; Zhe Xu; Wei-Su Li; Xue-Quan Yao; Fu-Kun Liu
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

Review 6.  Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.

Authors:  Zhi-Feng Miao; Xing-Yu Liu; Zhen-Ning Wang; Ting-Ting Zhao; Ying-Ying Xu; Yong-Xi Song; Jin-Yu Huang; Hao Xu; Hui-Mian Xu
Journal:  BMC Cancer       Date:  2018-01-31       Impact factor: 4.430

Review 7.  Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials.

Authors:  A-Man Xu; Lei Huang; Wei Liu; Shuang Gao; Wen-Xiu Han; Zhi-Jian Wei
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

8.  Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis.

Authors:  Jun-Hua Zhao; Peng Gao; Yong-Xi Song; Jing-Xu Sun; Xiao-Wan Chen; Bin Ma; Yu-Chong Yang; Zhen-Ning Wang
Journal:  BMC Cancer       Date:  2016-08-12       Impact factor: 4.430

Review 9.  Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?

Authors:  Rossella Reddavid; Silvia Sofia; Paolo Chiaro; Fabio Colli; Renza Trapani; Laura Esposito; Mario Solej; Maurizio Degiuli
Journal:  World J Gastroenterol       Date:  2018-01-14       Impact factor: 5.742

10.  Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only.

Authors:  Jinfeng Wang; Huacun Shi; Guang Yang; Guangjie Han; Man Zhao; Xiaoling Duan; Lili Mi; Xin Han; Ning Li; Jianfei Shi; Xiaolei Yin; Fei Yin
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.